India, Dec. 5 -- This is a trying phase for Washington Sundar. On a dry, up and down Eden Gardens pitch, he was given only one over across two innings but had to bat out of his skin at No 3. He lost t... Read More
Charar-i-Shareef, Dec. 5 -- Alamdar Memorial College of Nursing and Medical Technology, Islamic University of Science and Technology, Charar-i-Shareef, observed World AIDS Day today by organizing a se... Read More
Nigeria, Dec. 5 -- A new report by the Gates Foundation has revealed that long-acting HIV prevention tools, such as lenacapavir, the twice-yearly HIV-prevention injection, offer some of the strongest ... Read More
India, Dec. 5 -- The US government has tightened its vetting process for H-1B visa applicants and their H-4 dependents, introducing mandatory social media screening for all applicants starting Decembe... Read More
Srinagar, Dec. 5 -- The Institution of Engineers (India), Jammu & Kashmir State Centre (IEIJKSC), inaugurated the first day of its two-day national workshop, "Zabaan-o-Bunyad: Empowering Non-Engineer ... Read More
India, Dec. 5 -- Cooperation on small modular reactors and the selection of a site for building a second nuclear power plant with Russian reactors figured in the India-Russia Summit on Friday, with th... Read More
U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07263919) titled 'Perioperative Cadonilimab Combined With Neoadjuvant Chemotherapy in Resectable Esophageal Sq... Read More
U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264140) titled 'Assessing and Improving Misuse of Inhalers in COPD Outpatients' on Nov. 24. Brief Summary: ... Read More
U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07262840) titled 'Health Behavior Change in High-Risk Colorectal Cancer Individuals' on Nov. 19. Brief Summar... Read More
U.S., Dec. 5 -- ClinicalTrials.gov registry received information related to the study (NCT07264517) titled 'Evaluating the Safety, Tolerability, and Efficacy of GRF312 5% in Participants With Dry Eye ... Read More